Freedom Biosciences
Founded 2021 · 11 employees on LinkedIn · 7 known investors
Freedom Biosciences develops neuropsychiatric therapeutics, focusing on novel treatments for conditions including depression, PTSD, and alcoholism. The company advances drug candidates through clinical development and regulatory pathways, serving patients with mental health and neurological disorders.
Founders & leadership
Freedom Biosciences was founded in 2021 by Dr. John Krystal and Dina Burkitbayeva.
DJ
DB
Investors · 7
Competitors · 2
by search overlap
Doximity6 shared keywordsDoximity is the largest verified network of healthcare professionals in the U.S., connecting physicians, PAs, NPs, pharmacists, and medical students across specialties and care settings. The platform provides mobile-first tools for clinical communication, collaboration, and workflow optimization.
Clearmind Medicine6 shared keywordsClearmind Medicine is a clinical-stage biotech developing proprietary psychedelic-based treatments, with a focus on alcohol use disorder and related conditions. Its therapies are designed to be self-administered, and the company is publicly listed on the Nasdaq (CMND) and Frankfurt Stock Exchange (CWY0).
Companies competing with Freedom Biosciences for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Freedom Biosciences do?
- Freedom Biosciences develops neuropsychiatric therapeutics, focusing on novel treatments for conditions including depression, PTSD, and alcoholism. The company advances drug candidates through clinical development and regulatory pathways, serving patients with mental health and neurological disorders.
- Who founded Freedom Biosciences?
- Freedom Biosciences was founded by Dr. John Krystal, Dina Burkitbayeva in 2021.
- Who are Freedom Biosciences's investors?
- Freedom Biosciences's investors include Beni Venture Capital, Iter Investments, LongeVC, Manta Ray Ventures, PsyMed Ventures, Unruly Capital, MBX Capital.